DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0242383 | Age related macular degeneration | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0023434 | Chronic Lymphocytic Leukemia | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0242379 | Malignant neoplasm of lung | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0027651 | Neoplasms | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0033578 | Prostatic Neoplasms | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0022658 | Kidney Diseases | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0678222 | Breast Carcinoma | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0029456 | Osteoporosis | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0205645 | Adenocarcinoma, Tubular | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C1306459 | Primary malignant neoplasm | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0205641 | Adenocarcinoma, Basal Cell | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0268398 | Familial lichen amyloidosis | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C3887461 | Head and Neck Carcinoma | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0684249 | Carcinoma of lung | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0205644 | Carcinoma, Granular Cell | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C1565489 | Renal Insufficiency | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0376545 | Hematologic Neoplasms | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0699790 | Colon Carcinoma | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C2931822 | Nasopharyngeal carcinoma | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0038013 | Ankylosing spondylitis | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0024121 | Lung Neoplasms | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0006826 | Malignant Neoplasms | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0009402 | Colorectal Carcinoma | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0007103 | Malignant neoplasm of endometrium | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
C0205643 | Carcinoma, Cribriform | UGT2B17 | 7367 | UDP glucuronosyltransferase family 2 member B17 | O75795 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024